Clinical Trial Update: Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Cadisegliatin as adjunctive therapy to insulin in people with Type 1 diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Cadisegliatin

Snippet

Sponsor: vTv Therapeutics | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: RECRUITING